Global High Content Screening Market 2022-2028

According to market research study published by Gen Consulting Company, the global high content screening market stood at around USD 1,105 million in 2021 and is projected to rise to a worth of USD 2,046 million by 2028 end, thereby garnering a CAGR of 9.2% during 2022-2028.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global high content screening market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the high content screening industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the component, application, end user, and region. The global market for high content screening can be segmented By component consumables (reagents and kits), instrument or platform, services, software and analytics. The instrument or platform segment held the largest revenue share in 2021. High content screening market is further segmented By applicationt compound profiling, drug discovery, molecular diagnosis, oncology, toxicity studies, others. Among these, the drug discovery segment was accounted for the highest revenue generator in 2021. Based on end user, the high content screening market is segmented into: academic institutions, laboratories and pathology centers, pharmaceutical and biotechnology companies. The pharmaceutical and biotechnology companies segment captured the largest share of the market in 2021. On the basis of region, the high content screening market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By component:
- consumables (reagents and kits)
- instrument or platform
- services
- software and analytics

By applicationt:
- compound profiling
- drug discovery
- molecular diagnosis
- oncology
- toxicity studies
- others

By end user:- academic institutions
- laboratories and pathology centers
- pharmaceutical and biotechnology companies

By region:
- Asia Pacific
- Europe
- North America
- Rest of the World (RoW)

The instrument market is further segmented into cytometers, detectors and sensors, imaging devices, liquid handling instruments, plate readers, others. Globally, the imaging devices segment made up the largest share of the high content screening market.

The report has also analysed the competitive landscape of the global high content screening market with some of the key players being Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Danaher Corp., GE Healthcare, Merck KGaA, Olympus Corporation, PerkinElmer, Inc., Sartorius AG, Thermo Fisher Scientific Inc., Yokogawa Electric Corporation, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
- To analyze and forecast the market size of the global high content screening market.
- To classify and forecast the global high content screening market based on component, application, end user, region.
- To identify drivers and challenges for the global high content screening market.
- To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global high content screening market.
- To identify and analyze the profile of leading players operating in the global high content screening market.

Why Choose This Report
- Gain a reliable outlook of the global high content screening market forecasts from 2022 to 2028 across scenarios.
- Identify growth segments for investment.
- Stay ahead of competitors through company profiles and market data.
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
TABLE OF CONTENTS
FIGURES AND TABLES
PART 1. INTRODUCTION
Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience
PART 2. METHODOLOGY
PART 3. EXECUTIVE SUMMARY
PART 4. MARKET OVERVIEW
Introduction
Drivers
Restraints
Impact of COVID-19 pandemic
PART 5. MARKET BREAKDOWN BY COMPONENT
Consumables (reagents and kits)
Instrument or platform
Services
Software and analytics
PART 6. MARKET BREAKDOWN BY APPLICATION
Compound profiling
Drug discovery
Molecular diagnosis
Oncology
Toxicity studies
Others
PART 7. MARKET BREAKDOWN BY END USER
Academic institutions
Laboratories and pathology centers
Pharmaceutical and biotechnology companies
PART 8. MARKET BREAKDOWN BY REGION
Asia Pacific
Europe
North America
Rest of the World (RoW)
PART 9. KEY COMPANIES
Agilent Technologies Inc.
Bio-Rad Laboratories, Inc.
Danaher Corp.
GE Healthcare
Merck KGaA
Olympus Corporation
PerkinElmer, Inc.
Sartorius AG
Thermo Fisher Scientific Inc.
Yokogawa Electric Corporation
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER

Global Whole Exome Sequencing Market 2023

DescriptionThe Whole Exome Sequencing Market is poised for substantial growth, with a projected increase from USD 1.43 billion in 2022 to USD 3.75 billion by 2029. This growth is expected

USD 1950 View Report

Global Continuous Bioprocessing Market 2023

DescriptionThe global Continuous Bioprocessing Market size is anticipated to expand from USD 133.9 million in 2022 to USD 443.1 million by 2029, registering a compound annual growth rate (CAGR) of

USD 1950 View Report

Global High Purity Alumina (HPA) Market 2023

DescriptionThe global HPA market is projected to rise by USD 180.0 million by 2029, according to the latest market study results. It is anticipated to expand at a CAGR of

USD 3550 View Report

Global High-performance Tires Market 2023

According to the latest research, the global high-performance tires market is poised to grow by USD 19.6 billion during 2023-2029, progressing at a CAGR of 6.1% during the forecast period.

USD 2350 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available